High expression of caspase‐8 as a predictive factor of poor prognosis in patients with esophageal cancer

por Chai, Jian, Lei, Yongqiang, Xiang, Xindong, Ye, Jing, Zhao, Hang, Yi, Lili
Publicado 2022

New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bev...

por Tada, Toshifumi, Kumada, Takashi, Hiraoka, Atsushi, Kariyama, Kazuya, Tani, Joji, Hirooka, Masashi, Takaguchi, Koichi, Atsukawa, Masanori, Fukunishi, Shinya, Itobayashi, Ei, Tsuji, Kunihiko, Tajiri, Kazuto, Ochi, Hironori, Ishikawa, Toru, Yasuda, Satoshi, Ogawa, Chikara, Toyoda, Hidenori, Hatanaka, Takeshi, Nishimura, Takashi, Kakizaki, Satoru, Kawata, Kazuhito, Shimada, Noritomo, Tada, Fujimasa, Nouso, Kazuhiro, Tsutsui, Akemi, Ohama, Hideko, Morishita, Asahiro, Nagano, Takuya, Itokawa, Norio, Okubo, Tomomi, Arai, Taeang, Kosaka, Hisashi, Imai, Michitaka, Naganuma, Atsushi, Nakamura, Shinichiro, Koizumi, Yohei, Kaibori, Masaki, Iijima, Hiroko, Hiasa, Yoichi
Publicado 2022

LncRNA SPRY4‐IT1 facilitates cell proliferation and angiogenesis of glioma via the miR‐101‐3p/EZH2/VEGFA signaling axis

por Wang, Ji, Chen, Yanming, Wang, Qing, Xu, Hui, Jiang, Qianqian, Wang, Man, Li, Shenggang, Chen, Ying, Wu, Chunwang, Yu, Pei, Xiao, Zongyu, Chen, Wenjin, Lan, Qing
Publicado 2022

Peripheral blood kinetics following total body irradiation and allogeneic hematopoietic stem cell transplantation: Timing matters

por Dejonckheere, Cas S., Böhner, Alexander M. C., Schmitz, Eva, Holderried, Tobias A. W., Schmeel, Leonard C., Brossart, Peter, Giordano, Frank A., Köksal, Mümtaz A.
Publicado 2022

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma

por Su, Chung‐Wei, Teng, Wei, Lin, Po‐Ting, Jeng, Wen‐Juei, Chen, Kuei‐An, Hsieh, Yi‐Chung, Chen, Wei‐Ting, Ho, Ming‐Mo, Hsieh, Chia‐Hsun, Wang, Ching‐Ting, Chai, Pei‐Mei, Lin, Chen‐Chun, Lin, Chun‐Yen, Lin, Shi‐Ming
Publicado 2022

Deep learning‐based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia

por Zhang, Xinyi, Gleber‐Netto, Frederico O., Wang, Shidan, Martins‐Chaves, Roberta Rayra, Gomez, Ricardo Santiago, Vigneswaran, Nadarajah, Sarkar, Arunangshu, William, William N., Papadimitrakopoulou, Vassiliki, Williams, Michelle, Bell, Diana, Palsgrove, Doreen, Bishop, Justin, Heymach, John V., Gillenwater, Ann M., Myers, Jeffrey N., Ferrarotto, Renata, Lippman, Scott M., Pickering, Curtis Rg, Xiao, Guanghua
Publicado 2023

Controlled register‐based study of road traffic accidents in 12,651 Finnish cancer patients during 2013–2019

por Huuskonen, Marja‐Liisa, Koistinen, Tero, Sihvola, Niina, Parkkari, Inkeri, Palovaara, Sanna, Kytö, Ville, Sipilä, Jussi, Jyrkkiö, Sirkku, Heervä, Eetu
Publicado 2022

A 5‐year survival status prognosis of nonmetastatic cervical cancer patients through machine learning algorithms

por Yu, Wenke, Lu, Yanwei, Shou, Huafeng, Xu, Hong’en, Shi, Lei, Geng, Xiaolu, Song, Tao
Publicado 2022

Differential adoption of castration‐resistant prostate cancer treatment across facilities in a national healthcare system

por Caram, Megan E. V., Kumbier, Kyle, Burns, Jennifer, Sparks, Jordan B., Tsao, Phoebe A., Stensland, Kristian D., Washington, Samuel L., Hollenbeck, Brent K., Shahinian, Vahakn, Skolarus, Ted A.
Publicado 2023

Cancer‐related knowledge, beliefs, and behaviors among Hispanic/Latino residents of Indiana

por Espinoza‐Gutarra, Manuel R., Rawl, Susan M., Maupome, Gerardo, O'Leary, Heather A., Valenzuela, Robin E., Malloy, Caeli, Golzarri‐Arroyo, Lilian, Parker, Erik, Haunert, Laura, Haggstrom, David A.
Publicado 2023

Computed tomography‐based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma

por He, Hongchao, Jin, Zhijia, Dai, Jun, Wang, Haofei, Sun, Jianqi, Xu, Danfeng
Publicado 2022

On target methods to induce abscopal phenomenon for Off‐Target effects: From happenstance to happenings

por Nelson, Blessie Elizabeth, Adashek, Jacob J., Lin, Steven H., Subbiah, Vivek
Publicado 2022

Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study

por Wu, Guodong, Li, Jing, Li, Changfeng, Ou, Xia, Feng, Kai, Xia, Feng, Chen, Zhiyu, Zhang, Leida, Ma, Kuansheng
Publicado 2022

Patterns of use of biological and genetic markers for chronic lymphocytic leukemia and acute myeloid leukemia in Puerto Rico

por Ortiz‐Ortiz, Karen J., Torres‐Cintrón, Carlos R., Suárez Ramos, Tonatiuh, Castañeda‐Avila, Maira A., Cotto Santana, Luis A., Tortolero‐Luna, Guillermo
Publicado 2022

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma

por Park, Sehhoon, Cha, Hongui, Kim, Hong Sook, Lee, Boram, Kim, Soyeon, Kim, Tae Min, Jung, Hyu Ae, Sun, Jong‐Mu, Ahn, Jin Seok, Ahn, Myung‐Ju, Park, Keunchil, Park, Woong‐Yang, Lee, Se‐Hoon
Publicado 2022

APOBEC3A/B deletion polymorphism and endometrial cancer risk

por Sofiyeva, Nigar, Krakstad, Camilla, Halle, Mari K., O'Mara, Tracy A., Romundstad, Pål, Hveem, Kristian, Vatten, Lars, Lønning, Per E., Gansmo, Liv B., Knappskog, Stian
Publicado 2022

Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early‐stage hormone‐receptor‐positive breast cancer...

por Shen, Chan, Li, Ning, Zhou, Shouhao, Stahl, Kelly, Dodge, Daleela, Zhao, Hui
Publicado 2022

Biomarkers predictive of response to pembrolizumab in head and neck cancer

por Pfister, David G., Haddad, Robert I., Worden, Francis P., Weiss, Jared, Mehra, Ranee, Chow, Laura Q. M., Liu, Stephen V., Kang, Hyunseok, Saba, Nabil F., Wirth, Lori J., Sukari, Ammar, Massarelli, Erminia, Ayers, Mark, Albright, Andrew, Webber, Andrea L., Mogg, Robin, Lunceford, Jared, Huang, Lingkang, Cristescu, Razvan, Cheng, Jonathan, Seiwert, Tanguy Y., Bauml, Joshua M.
Publicado 2022

CD79B Y196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma

por Yamaguchi, Junya, Ohka, Fumiharu, Lushun, Chalise, Motomura, Kazuya, Aoki, Kosuke, Takeuchi, Kazuhito, Nagata, Yuichi, Ito, Satoshi, Mizutani, Nobuhiko, Ohno, Masasuke, Suzaki, Noriyuki, Takasu, Syuntaro, Seki, Yukio, Kano, Takahisa, Wakabayashi, Kenichi, Oyama, Hirofumi, Kurahashi, Shingo, Tanahashi, Kuniaki, Hirano, Masaki, Shimizu, Hiroyuki, Kitano, Yotaro, Maeda, Sachi, Yamazaki, Shintaro, Wakabayashi, Toshihiko, Kondo, Yutaka, Natsume, Atsushi, Saito, Ryuta
Publicado 2022

Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers

por Mori, Tomoharu, Okamoto, Yusuke, Mu, Anfeng, Ide, Yoshimi, Yoshimura, Akiyo, Senda, Noriko, Inagaki‐Kawata, Yukiko, Kawashima, Masahiro, Kitao, Hiroyuki, Tokunaga, Eriko, Miyoshi, Yasuo, Ohsumi, Shozo, Tsugawa, Koichiro, Ohta, Tomohiko, Katagiri, Toyomasa, Ohtsuru, Shigeru, Koike, Kaoru, Ogawa, Seishi, Toi, Masakazu, Iwata, Hiroji, Nakamura, Seigo, Matsuo, Keitaro, Takata, Minoru
Publicado 2022